Log In
BCIQ
Print this Print this
 

TAM-01

  Manage Alerts
Collapse Summary General Information
Company Buck Institute for Research on Aging
Description mTOR inhibitor
Molecular Target Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of ActionMammalian target of rapamycin (mTOR) kinase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationLupus
Indication DetailsTreat systemic lupus erythematosus (SLE)
Regulatory Designation
PartnerMount Tam Biotechnologies Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/14/2015

Undisclosed

Undisclosed

Undisclosed

08/18/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today